SCI时时刷

search
Movement behavior in hemophilia—from medicalized training approaches toward an active lifestyle
Movement behavior in hemophilia—from medicalized training approaches toward an active lifestyle
In this issue of Research and Practice in Thrombosis and Haemostasis, McLaughlin and colleagues1 explore ways to support p...
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines
Abstract The recent American Society of Hematology/ISTH/National Hemophilia Foundation/World Federation of Hemophilia 2021...
Hemostatic phenotypes and genetic disorders
Hemostatic phenotypes and genetic disorders
Abstract This review is focused on genetic regulators of bleeding and thrombosis with a focus on next-generation sequencin...
Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis
Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis
Abstract Background Pulmonary endothelial injury and microcirculatory thromboses likely contribute to hypoxemic respirator...
Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
Abstract Background Negatively charged procoagulant phospholipids, phosphatidylserine (PS) in particular, are vital to coa...
Thrombo‐inflammatory biomarkers and D‐dimer in a biracial cohort study
Thrombo‐inflammatory biomarkers and D‐dimer in a biracial cohort study
Abstract Background Higher D-dimer is a risk factor for cardiovascular diseases and venous thromboembolism. In the general...
Social participation and hemophilia: Self‐perception, social support, and their influence on boys in Canada
Social participation and hemophilia: Self‐perception, social support, and their influence on boys in Canada
Abstract Background Patients with hemophilia may experience joint damage, which can impair participation, yet few studies ...
Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
Abstract Background Medication nonadherence can result in poor clinical outcomes and significant costs to health care prov...
Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
Abstract The goat model of atrial fibrillation (AF) allows investigation of the effect of AF on coagulation. However, assa...
Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case
Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case
Abstract Afibrinogenemia and congenital dysfibrinogenemia (CD) are rare conditions with limited information available for ...
Abstracts from the CanVECTOR 2021 Annual Conference November 5th, 2021
Abstracts from the CanVECTOR 2021 Annual Conference November 5th, 2021
An Observational Pilot Study Investigating the Role of Coagulation in the Diagnosis of SEPSIS in the Emergency Department...
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
Abstract Background Rivaroxaban was reported as effective as traditional therapies for the acute treatment of venous throm...